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Abstract
The canalicular plasma membrane is constantly exposed to bile acids acting as detergents. Bile acids are
essential to mediate release of biliary lipids from the canalicular membrane. Membrane microdomains
(previously called lipid rafts) are biochemically defined by their resistance to detergent solubilization at
cold temperature. We aimed to investigate the canalicular plasma membrane for the presence of
microdomains, which could protect this membrane against the detergent action of bile acids. Highly
purified rat liver canalicular plasma membrane vesicles were extracted with 1% Triton X-100 or 1%
Lubrol WX at 4 degrees C and subjected to flotation through sucrose step gradients. Both detergents
yielded detergent-resistant membranes containing the microdomain markers alkaline phosphatase and
sphingomyelin. However, cholesterol was resistant to Lubrol WX solubilization, whereas it was only
marginally resistant to solubilization by Triton X-100. The microdomain marker caveolin-1 was
localized to the canalicular plasma membrane domain and was resistant to Lubrol WX, but to a large
extent solubilized by Triton X-100. The two additional microdomain markers, reggie-1 and reggie-2,
were localized to the basolateral and canalicular plasma membrane and were partially resistant to Lubrol
WX but resistant to Triton X-100. The canalicular transporters bile salt export pump, multidrug
resistance protein 2, multidrug resistance-associated protein 2, and Abcg5 were largely resistant to
Lubrol WX but were solubilized by Triton X-100. Conclusion: These results indicate the presence of
two different types of microdomains in the canalicular plasma membrane: "Lubrol-microdomains" and
"Triton-microdomains". "Lubrol-microdomains" contain the machinery for canalicular bile formation
and may be the starting place for canalicular lipid secretion.
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The canalicular plasma membrane is constantly exposed to bile acids acting as 
detergents. Bile acids are essential to mediate release of biliary lipids from the 
canalicular membrane. Membrane microdomains (previously called lipid rafts) are 
biochemically defined by their resistance to detergent solubilization at cold 
temperature. We aimed to investigate the canalicular plasma membrane for the 
presence of microdomains, which could protect this membrane against the detergent 
action of bile acids. Highly purified rat liver canalicular plasma membrane vesicles 
were extracted with 1% TritonX-100 or 1% LubrolWX at 4°C and subjected to 
flotation through sucrose step gradients. Both detergents yielded detergent resistant 
membranes containing the microdomain markers alkaline phosphatase and 
sphingomyelin. However, cholesterol was resistant to LubrolWX solubilization, while 
it was only marginally resistant to solubilization by TritonX-100. The microdomain 
marker caveolin-1 was localized to the canalicular plasma membrane domain and was 
resistant to LubrolWX, but to a large extent solubilized by TritonX-100. The two 
additional microdomain markers reggie-1 and reggie-2 were localized to the 
basolateral and canalicular plasma membrane and were partially resistant to 
LubrolWX but resistant to TritonX-100. The canalicular transporters bile salt export 
pump, multidrug resistance protein 2, multidrug resistance-associated protein 2 and
Abcg5 were largely resistant to LubrolWX but were solubilized by TritonX100. 
Conclusion: These results indicate the presence of two different types of 
microdomains in the canalicular plasma membrane: "Lubrol-microdomains" and 
"Triton-microdomains". "Lubrol-microdomains" contain the machinery for 
canalicular bile formation and may be the starting place for canalicular lipid secretion. 




Bile formation involves vectorial secretion of bile acids and other cholephilic 
compounds across hepatocytes from the sinusoidal blood plasma into bile canaliculi 
(1, 2). The main bile constituents are bile salts, organic anions, phospholipids and 
cholesterol which aggregate in bile into mixed micelles (3). Hence, bile fluid is 
exquisitely suited for the excretion of water insoluble substances. The most important 
transporters involved in canalicular secretion of bile salts, organic anions and 
phosphatidylcholine are the bile salt export pump Bsep (Abcb11) (BSEP in humans) 
(4, 5), the multidrug resistance associated protein 2 Mrp2 (Abcc2) (MRP2 in humans)
(6), and the phosphatidylcholine translocator Mdr2 (Abcb4) (MDR3 in humans), (7), 
respectively. Export of cholesterol from the canalicular plasma membrane (cLPM) is 
mediated by the heterodimeric protein Abcg5/Abcg8 (ABCG5/ABCG8 in humans) 
(8). All these transporters are members of the ATP-binding cassette (ABC) protein 
superfamily and utilize ATP-hydrolysis for transport function. 
Canalicular phospholipid secretion has been extensively studied both in inherited 
human liver disease and in animal models. The results indicate that, once secreted into 
the bile canaliculi, bile salts extract phosphatidylcholine from the outer leaflet of the 
cLPM and solubilize it within mixed micelles (3). This principle has been worked out 
in various animal models, which demonstrated that in the absence of bile salt 
secretion canalicular phospholipid secretion ceases. However, in mice with disrupted 
Mdr2 function, phospholipid secretion cannot be stimulated, even at high rates of bile 
salt output (9). This highlights the importance of functional Mdr2 for canalicular 
phospholipid secretion. Furthermore, inherited forms of human liver diseases with 
defective expression and/or function of BSEP (e.g. Progressive Familial Intrahepatic 
Cholestasis type 2, PFIC 2) or of MDR3 (PFIC 3) provide strong evidence that the 
same mechanism of biliary phospholipid secretion is also valid in human liver (10). 




Furthermore, the finding that animals without biliary phospholipid secretion display 
no biliary cholesterol secretion (9) demonstrates that the presence of mixed bile 
salt/phospholipid micelles is required in bile in order to maintain normal cholesterol 
secretion. In addition, the heterodimeric ABC transporter Abcg5/Abcg8 is involved in 
canalicular cholesterol secretion, since 1) mice with disrupted Abcg5 or Abcg8 
display a marked reduction in biliary cholesterol secretion (11), and 2) patients with 
mutations in the ABCG5/ABCG8 gene display hypercholesterolemia and E-
sitosterolemia (8). Hence, at least the three ABC-transporters Bsep, Mdr2 and 
Abcg5/Abcg8 are needed for the maintenance of normal biliary cholesterol secretion 
(3). The exact role of an ATP-independent phosphatidylcholine translocator that is 
also expressed at the cLPM, is not understood at present (12, 13). 
In vitro, bile salts preferentially extract phosphatidylcholine from the cLPM, 
albeit phosphatidylcholine represents only 35% of total canalicular phospholipids (14, 
15) and the cLPM has an exceptionally high sphingomyelin content (15). This unique 
property of the cLPM could be due to the presence of lipid microdomains such as for 
example detergent sensitive membrane regions enriched in phospholipids and 
detergent resistant sphingomyelin/cholesterol clusters, which are also called lipid rafts 
(16, 17). In such microdomains, sphingomyelin and cholesterol are arranged in a 
tightly packed, liquid-order state (16) forming highly dynamic structures, which exist 
in short length and time scales (18). Recently, evidence has been provided for the 
presence of coexisting raft and non-raft microdomains in both the basolateral plasma 
membrane domain (blLPM) and the cLPM domain of rat hepatocytes (19, 20). In 
these studies the TritonX-100 resistant lipid microdomains were enriched in alkaline 
phosphatase (AP), caveolin-1, cholesterol, sphingomyelin, the ganglioside GM1 and 
the aquaporins 8 (canalicular) and 9 (basolateral) (20). Other studies have indicated 




that the hepatocyte plasma membrane might contain at least two different pools of 
cholesterol and caveolin-1 enriched microdomains, the major one (~ 90%) being 
soluble and the minor one (~ 10%) being insoluble in TritonX-100 (1%) (21). 
Furthermore, the coexistence of different cholesterol-enriched lipid microdomains has 
been proposed in the apical membrane of MDCK cells based on its relative solubility 
in the non-ionic detergents TritonX-100 ("Triton microdomains") and LubrolWX
("Lubrol microdomains") (22). And finally, in neurons and astrocytes, caveolin-1 
negative lipid microdomains have been identified that are associated with the marker 
proteins reggie-1/flotillin-2 and reggie-2/flotillin-1 (23-26). Reggie proteins are 
widely expressed, form oligomers at the cytoplasmic face of the plasma membrane 
(27) and scaffolds of plasma membrane microdomains, which are clearly distinct from 
caveolae (28). Reggie microdomains represent platforms for multiprotein complex 
formation and signal transduction in a cell-type and situation-specific manner (29, 
30). They communicate, for instance, with Rho-GTPases and regulate actin 
cytoskeleton dynamics (31). Hence, heterogeneous lipid microdomains might coexist 
at the two polar plasma membrane domains of epithelial cells and differentially 
influence vectorial transport processes such as hepatocellular bile formation. 
In this study, we investigated the hypothesis that distinct lipid microdomains 
with different protein and lipid compositions and different sensitivities toward non-
ionic detergents (LubrolWX, TritonX-100) might coexist at the cLPM of rat 
hepatocytes. Furthermore, we wondered whether the canalicular ABC transporters are 
partially or even completely compartmentalized into distinct lipid microdomains. 





Antibodies and the methods describing the extraction and analysis of lipids, SDS-
polyacrylamide gel electrophoresis and immunoblotting, immunofluorescence and 
immunoelectron microscopy are given in a file containing supplementary material. 
Animals: Male Sprague-Dawley rats (180-200g) were obtainedd from Harlan (Horst, 
The Netherlands). They received humane care in accordance with local and federal 
guidelines and regulations were kept under standard conditions. 
Chemicals: LubrolWX and TritonX-100 were purchased from Serva Feinbiochemica 
(Heidelberg, Germany) and MP Biomedicals (Irvine, CA), respectively. Lipid 
standards were from Sigma-Aldrich (St. Louis, MO). All other chemicals were of the 
highest grade and readily available from commercial sources. 
Isolation of detergent resistant microdomains (DRMs) from highly purified 
cLPM: cLPM we re isolated as described (32) and stored in liquid nitrogen until use. 
DRMs were isolated by performing all steps at 4°C with minor modifications as 
described (33). Briefly: cLPM (1mg protein) were thawed on ice and diluted to 1ml in 
TNE (150mM NaCl, 1mM EDTA, 20mM Tris-HCl pH7.4) containing antipain and 
leupeptin 2µg/ml each and 1mM phenylmethylsulfonylfluoride. The suspension was 
mixed with 1ml of either 2%(w/vol) LubrolWX or 2%(w/vol) TritonX-100 in TNE 
(yielding a detergent to protein ratio (w/w) of 20) and homogenized by passing it ten 
times through a 25-gauge needle. After incubation for 30min on ice, the suspension 
was brought to 40%(w/vol) sucrose by adding 2ml 80%(w/vol) sucrose in TNE. This 
mixture was overlaid with 5ml 35%(w/vol) and 4ml 5%(w/vol) sucrose both in TNE. 




The DRMs were floated by centrifugation for 18h at 40,000rpm (270,000gav), 4°C in 
a TST41.14 swinging bucket rotor from Kontron Instruments (Schlieren, 
Switzerland). Twelve 1ml fractions were harvested from the top and the pellet was 
resuspended in 1ml TNE by vigorous vortexing and 10 passages through a 25-gauge 
needle. AP activity in the presence of 0.2mM ZnSO4 was measured immediately as 
described (34). For all other analyses, the fractions were stored in aliquots at –80°C 
until used. 





In order to test whether the cLPM of rat liver contains DRMs, we exposed 
cLPM vesicles from rat liver to the two non-ionic detergents LubrolWX and TritonX-
100. As indicated in Fig.1, after cold extraction of cLPM with 1%(w/vol) LubrolWX 
24% of total cLPM protein (Fig.1A) and 88% of total canalicular AP activity (Fig.1B) 
floated to the top of the 35% sucrose layer during ultracentrifugation (fractions 3-5, 
Fig.1), i.e. they were not solubilized by LubrolWX and, thus, associated with 
LubrolWX- resistant membrane microdomains (so called "Lubrol-microdomains"). 
For 1%(w/vol) TritonX-100, the corresponding numbers were 10% (total protein) and 
85% (AP activity), respectively (Fig.1). Hence, the vast majority of the canalicular AP 
activity was recovered in the DRMs after extraction with either detergent. Using 
2%(w/vol) instead of 1%(w/vol) TritonX-100 showed no difference in the distribution 
of AP activity after flotation, while extraction with 0.5%(w/vol) TritonX-100 resulted 
in a lower recovery of detergent resistant AP activity (data not shown). Consequently, 
subsequent experiments were performed with 1%(w/vol) TritonX-100. Increasing 
LubrolWX concentration to 2%(w/vol) did not alter the amount of protein floating to 
the DRMs, nor the distribution pattern of canalicular proteins between solubilized and 
DRM fractions on the gradient (data not shown). Therefore, a LubrolWX 
concentration of 1%(w/vol) was chosen for this study. These data indicate that the 
cLPM of rat liver contains indeed DRMs that harbor a significant proportion of 
membrane-associated proteins and are highly enriched in GPI-anchored AP, which 
represents a typical marker enzyme for DRMs (35). 
To further characterize the canalicular "Lubrol microdomains" and "Triton 
microdomains", we analyzed the low-density membrane material recovered from 
fractions 3-5 with respect to additional DRM marker proteins such as caveolin-1 and 




reggie-1 and reggie-2. In addition, the cytoskeletal protein actin was probed for to 
investigate a possible association of cytoskeletal elements with the two canalicular 
DRMs. As shown in Fig.2, caveolin-1 was mostly resistant to LubrolWX (fractions 3-
5), but almost completely solubilized by TritonX-100 (fractions 8-12). In contrast, 
reggie-1 and reggie-2 were completely resistant to TritonX-100 in this system (Fig.2, 
fractions 3-5). And finally, actin was found to be associated with detergent soluble 
and detergent resistant cLPM subfractions indicating no preferential interaction with 
canalicular DRMs. These data support the presence of distinct DRMs at the cLPM of 
rat liver. They demonstrate that solubilization of cLPM with LubrolWX or TritonX-
100 results in cLPM microdomains of different marker protein composition. "Lubrol-
microdomains" contain quantitatively caveolin-1, and "Triton-microdomains" are 
associated with reggie-1 and reggie-2. 
The strong association of caveolin-1 with detergent-insoluble (LubrolWX) and 
detergent-soluble (TritonX-100) cLPM subfractions (Fig.2) was surprising, since the 
liver has been reported to express only low levels of caveolin-1 (36) and the 
subcellular distribution of caveolin-1 in rat liver has remained controversial (37-39). 
Therefore, we investigated the exact hepatocellular surface distribution of caveolin-1 
in more detail and compared it with established basolateral and canalicular marker 
proteins as well as with the surface distribution of reggie-1 and reggie-2. As 
illustrated in Fig.3A, in Western blot analysis of isolated blLPM and cLPM caveolin-
1 exhibited an exclusive canalicular localization as especially evidenced by its 
colocalization with the canalicular marker enzyme APN. In contrast, the expression of 
reggie-1 and reggie-2 was not domain-specific, but evenly distributed between blLPM 
and cLPM of rat hepatocytes. The antigen 1/18 has been previously shown to
represent a valid basolateral marker protein in rat hepatocytes (40). 




The canalicular localization of caveolin-1 was further confirmed by 
immunofluorescence studies using Mrp2 as a canalicular marker (Fig.3B). 
Immunopositive caveolin-1 was clearly associated with the cLPM (Fig.3C) and 
colocalized with canalicular Mrp2 (Fig.3D). However, green caveolin-1 
immunoreactivity was also seen along he sinusoidal lining of hepatocytes 
(Figs.3C,D). Since isolated blLPM were virtually devoid of immunopositive caveolin-
1 (Fig.3A), the apparent sinusoidal caveolin-1 positivity was most probably due to 
caveolin-1 with endothelial cells, where it is highly expressed (41), although low level 
expression of caveolin-1 at the blLPM of hepatocytes cannot be definitely excluded 
(38). In any case, the data demonstrate that caveolin-1 is a highly expressed and 
intrinsic protein of the cLPM domain of rat hepatocytes and, thus, can be used as a 
marker protein of canalicular DRMs in rat liver. The non-polar expression of reggie-1 
in hepatocytes (Fig.3A) was confirmed by immunofluorescence localization (Fig.3E).
We next used immunoelectron microscopy to more precisely localize Mrp2 and 
caveolin-1 in the cLPM. Since aldehyde fixation of liver tissue abolished reactivity of 
the anti-caveolin-1 antibody, methanol fixation had to be applied. This resulted in a 
satisfactory structural preservation of bile canaliculi in ultrathin frozen sections 
(Fig.4A) and at the same time permitted simultaneous immunogold localization of 
caveolin-1 and Mrp2 (Fig.4A,B). As previously reported (42), immunogold labeling 
for Mrp2 was intense at the microvilli of the bile canaliculi. As expected from the 
confocal immunofluorescence result for caveolin-1, immunogold labeling for 
caveolin-1 in ultrathin frozen sections of methanol-fixed liver was sparse but also 
detectable at microvilli and sub-plasma membrane regions of the bile capillaries. 
Inspecting the cLPM at higher magnification revealed again expression of both 
proteins and they were observed in proximity and hence corroborating the finding 




from the immunofluorescence experiment. However, the distance between the gold 
particles precludes a true colocalization. This might, at least in part, be the result of 
the methanol fixation method, which had to be used to detect caveolin-1. 
In addition to caveolin-1, reggie-1 and reggie-2, sphingomyelin represents an 
additional DRM marker (16). In fact, and as illustrated in Fig.5, sphingomyelin 
segregated quantitatively into both "Lubrol-microdomains" and "Triton-
microdomains" (fractions 3-5). This was not the case for cholesterol and various 
phospholipids. Hence, while the caveolin-1 positive "Lubrol-microdomains" (Fig.2) 
contained most canalicular phospholipids (except part of phosphatidylcholine) and all 
the cholesterol (Fig.5), the reggie-1 and reggie-2 positive "Triton-microdomains" 
(Fig.2) were devoid of any phospholipids and contained only a portion of canalicular 
cholesterol (Fig.5). While these data are consistent with LubrolWX being a less 
selective detergent for DRMs than TritonX-100 (43), they support further the 
presence of distinct canalicular DRMs. More specifically, the partial solubilization of 
cholesterol, but not sphingomyelin, by TritonX-100 indicates that part of the cLPM 
cholesterol is soluble independent of sphingomyelin and, thus, might represent a 
mobilizable cLPM cholesterol pool that can be extracted from the canalicular 
membrane together with phospholipids (especially phosphatidylcholine, Fig.5) by the 
detergent action of intracanalicular bile salts. 
Finally, we wondered about the segregation of some typical canalicular 
marker enzymes and canalicular ABC transporters within and outside "Lubrol-
microdomains" and "Triton-microdomain". As illustrated in Fig.6, the canalicular 
marker enzymes APN, ectoATPase and DPPIV were almost equally sensitive to 
solubilization by LubrolWX and TritonX-100. While APN and DPPIV minimally 
partitioned into both types of DRMs, ectoATPase could not be detected in DRMs at 




all (Fig.6). In contrast, the ABC transporters Abcg5, Bsep, Mrp2, Mdr2 and Mdr1 
were significantly associated with "Lubrol-microdomains" (Fig.7), while "Triton-
microdomains" contained only some minor portions of Mdr1 and even less so of 
Mrp2 (Fig.7). These data, while further supporting the existence of different types of 
canalicular DRMs, strongly indicate that canalicular ABC transporters function within 
phospholipids and cholesterol containing cLPM membrane microdomains (the 
caveolin-1 positive "Lubrol-microdomains") in rat hepatocytes. In contrast, reggie-1 
and reggie-2 positive "Triton-microdomains" might represent transporter free and 
sphingomyelin enriched, more rigid membrane microdomains that are important for 
the maintenance of the overall structural integrity and functional 
compartmentalization of the cLPM. 
Discussion
The present study provides evidence for the presence of two different types of 
DRMs in the cLPM of rat hepatocytes. Based on the detergents used for solubilization 
of isolated cLPMs we named the two distinct canalicular DRMs "Lubrol-
microdomains" and "Triton-microdomains". "Lubrol-microdomains" are associated 
quantitatively with caveolin-1 (Fig.2), contain the majority of canalicular cholesterol 
and phospholipids (Fig.5), portions of the marker enzymes APN and DDPIV (Fig.6) 
and large portions of all ABC transporters tested (i.e. Abcg5, Bsep, Mrp2, Mdr2 and 
Mdr1) (Fig.7). "Triton-microdomains" are associated quantitatively with AP (Fig.1), 
reggie-1 and reggie-2 (Fig.2), sphingomyelin (Fig.5) and contain also minor fractions 
of canalicular cholesterol (Fig.5), APN and DDPIV (Fig.6) as well as Mdr1 and Mrp2 
(Fig.7). Hence, our study supports the concept of distinct canalicular cholesterol-




enriched lipid microdomains that can be distinguished by the marker proteins 
caveolin-1 and reggie-1 and reggie-2. Furthermore, a large part of canalicular ABC 
transporters reside within the phospholipid and cholesterol enriched membrane 
regions ("Lubrol-microdomains") suggesting that they require a complex membrane 
lipid environment for proper functioning. 
By using the same two non-ionic detergents (e.g. LubrolWX and TritonX-
100), two distinct cholesterol-based lipid microdomains have previously been 
proposed in the apical plasma membrane of MDCK cells (22). Our findings support 
this previous study and extend the concept of the coexistence of multiple, distinct 
types of raft-like assemblies of lipids and proteins to the cLPM (apical) of 
hepatocytes. Although we have not tested further the exact localization of the distinct 
DRMs along the cLPM, due to a lack of suitable antibodies for immunoelectron 
microscopy, it is tempting to speculate that, similar to MDCK cells, the caveolin-1 
specific and lipid and transporter enriched "Lubrol-microdomains" may correspond to 
the microvillar portions, and the reggie-1 and reggie-2 and sphingomyelin specific 
"Triton-microdomains" to the more rigid planar portions of the cLPM. This 
interpretation would be compatible with several other previous reports: 1) Bsep, 
which is present in "Lubrol-microdomains", but absent from "Triton-microdomains" 
(Fig.7), has been shown to be preferentially localized in microvilli and to be virtually 
absent from planar portions of the cLPM (4), which is paralleled by scarce Mrp2 
labeling observed in this study, 2) reggie-1 and reggie-2 containing membrane 
microdomains ("Triton-microdomains" in this study, Fig.2) are clearly different from 
caveolin-1 containing membrane microdomains. They might represent stable 
membrane scaffolds or platforms with possible own regulatory functions that are 




distinct from caveolae (25), and 3) other ABC transporters (e.g. MDR1, MRP1) have 
been found to be associated with "Lubrol-microdomains" (44, 45). 
The association of a significant portion of ABC transporters (Fig.7) and all 
different lipid species (Fig.4) with "Lubrol-microdomains" indicates that ATP-
dependent canalicular bile salt, organic anion, phospholipid and cholesterol secretion 
requires a complex lipid environment for proper functioning. In this regard the high 
cholesterol content of "Lubrol-microdomains" appears especially interesting, since it 
has recently been shown in a heterologous expression system that the ATPase activity 
of the canalicular ABC-transporter ABCG2 is stimulated by cholesterol loading (46). 
As the methodology used to isolate DRMs has an inherent considerable quantitative 
variability (47), we could not quantitatively assess the enrichment of cholesterol in 
DRMs compared to cLPM. Nevertheless, by inserting or retrieving canalicular export 
systems into cholesterol enriched microdomains (i.e. "Lubrol-microdomains"), 
hepatocytes could regulate the activity of the ABC transporters and thus canalicular 
bile formation. Such a putative regulatory mechanism could also involve actin (Fig.2), 
as it was shown for insulin in rat liver plasma membrane microdomains (21, 48), as 
well as the cytoskeletal web and intermediate filaments underneath the cLPM (49, 
50). Furthermore, stimulation of the choleretic activity of hepatocytes leads to an 
upregulation of aquaporin-8 in caveolin-1 enriched canalicular microdomains (20). 
Also, partitioning of the serotonin transporter and the sodium-phosphate cotransporter 
into membrane microdomains has been demonstrated as a regulatory mechanism for 
these transporters (51, 52). Finally, and most importantly, the observation that 
LubrolWX was able to partially and preferentially solubilize phosphatidylcholine 
(Fig.5) mirrors the finding that taurocholate preferentially releases 
phosphatidylcholine from cLPM in vitro (15). Hence, caveolin-1 and ABC transporter 




positive "Lubrol-microdomains" might represent the canalicular microdomains from 
where biliary phospholipids are preferentially solubilized by intracanalicular bile 
salts. Although this latter conclusion remains to be experimentally verified, our data 
strongly suggest that "Lubrol-microdomains" are representative for cLPM 
microdomains that localize the entire functional machinery for maintenance of 
ongoing canalicular bile formation including bile salt (Bsep), organic anion (Mrp2), 
phospholipid (Mdr2) and cholesterol (Abcg5/8) secretion and therefore could also be 
called "bile salt microdomains". 
In contrast to "Lubrol-microdomains", "Triton-microdomains" appear to 
represent more stable non-caveolin-1 (caveolae) associated canalicular DRMs, which 
might not be directly involved in bile secretory processes. "Triton microdomains" 
contain notably fewer different lipid species than "Lubrol microdomains". To what 
extent different biophysical properties of the two different DRMS and to what extent 
the presence of inside-out and right-sight out oriented cLPM during detergent 
extraction contribute to this difference remains open at this moment. In addition, 
TritonX-100 is more selective in DRM isolation, such that it disrupts more lipid-
protein interactions than LubrolWX (43). While the association of "Triton 
microdomains" with AP, sphingomyelin and some cholesterol (Figs.1,5) is in 
agreement with previous findings (53), the observation of a specific association of 
reggie-1 and reggie-2 with "Triton-microdomains" is novel. Reggie-2/flotillin-1 upon 
its identification as a DRM component was found to be extracted together with 
caveolin-1 after cold extraction of 3T3-L1 adipocytes with TrionX-100 (54). 
However, electron microscopy studies have since shown that reggie proteins 
demarcate microdomains ("reggie-microdomains") distinct of caveolae in all cell 
types analyzed so far (23, 24, 55). Preliminary experiments showed only partial 




colocalization of reggie-1 and Mrp2 (data not shown), indicating a distinct expression 
of reggie-1 and caveolin-1 in the cLPM. In contrast, caveolin-1 and Mrp2 showed 
complete colocalization in the cLPM (Fig.3D). Opposite to 3T3-L1 cells, hepatocytes 
are highly polarized cells. Hence, the dissociation of Lubrol-microdomains and 
Triton-microdomains may be cell-type specific and/or related to the degree of cell 
polarity. This view is supported by the identification of distinct microdomains in the 
apical membrane of MDCK cells (22), which is paralleled by an expression of 
caveolin-1 and reggie-1 and reggie-2 in different membrane subdomains (56). While 
the expression of reggie-2 in mouse liver has been reported (57), in the same study 
expression of reggie-1 could not be demonstrated. The present study reports to our 
knowledge for the first time the expression of reggie-1 in liver and the localization of 
reggie-1 and reggie-2 to both plasma membrane domains of hepatocytes. The lack of 
detection of reggie-1 in the previous study may be due to the use of tissue lysates 
compared to highly purified and enriched plasma membrane fractions used in this 
study for Western blotting. 
In conclusion, by using LubrolWX and TritonX-100, we have presented strong 
evidence for the presence of to different microdomains in the cLPM of rat liver: 
"Lubrol-microdomains" and Triton-microdomains". The "Lubrol-microdomains" may 
play an essential role in canalicular bile formation, since they contain the entire 
machinery for the generation of canalicular bile salt dependent and independent bile 
flow.
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Figure1: Distribution of total protein (A) and AP (B) in detergent resistant 
microdomains (DRMs) isolated from cLPM. cLPM were extracted with 1%(w/vol) 
LubrolWX or 1%(w/vol) TritonX-100 and floated on discontinuous sucrose gradients 
as described in Materials and Methods. Twelve 1ml fractions were collected from the 
top and analyzed for protein content and AP activity. Low density fractions 3-5 
contained detergent resistant microdomains (i.e. "Lubrol-microdomains" (left panels) 
and "Triton-microdomains" (right panels)), high-density fractions 9-12 contain 
solubilized proteins. Fig.1A: The protein concentration in each fraction was 
determined as described in materials and methods. The total recovery in relation to the 
input was 95% for LubrolWX and 93% for TritonX-100. Fig.1B: AP activity was 
measured in the various fractions as described in Materials and Methods. AP was 
quantitatively recovered in both "Lubrol-microdomains" and "Triton-microdomains". 
The total recovery of AP relative to the total inputs was 95% for LubrolWX and 96% 
for TritonX-100. One representative result out of at least two independent 
experiments is shown.




Figure2: Distribution of the DRM markers caveolin-1, reggie-1 and reggie-2 
between canalicular "Lubrol-microdomains" and "Triton-microdomains".
cLPM were extracted with 1%(w/vol) LubrolWX (left panel) or 1%(w/vol) TritonX-
100 (right panel) and floated on discontinuous sucrose gradients as described in 
Materials and Methods. Fractions and the resuspended pellets (P) were subjected to 
Western blot analysis for marker proteins and actin. Untreated cLPM served as 
controls (C). Apparent molecular weights are given on the right. Caveolin-1 (Cav-1) 
was found to be associated predominantly with "Lubrol-microdomains", while reggie-
1 and reggie-2 were found to be distinct marker proteins for "Triton-microdomains". 
The cytoskeletal protein actin is only minimally associated with both types of DRMs. 
One representative result out of at least two independent experiments is shown.
Figure3: Immunological localization of caveolin-1 at the cLPM domain in 
isolated rat liver plasma membrane vesicles and in intact rat liver. A: blLPM and 
cLPM rat liver plasma membrane vesicles were isolated as described in Materials and 
Methods and probed with specific antibodies (Western blotting) against the indicated 
proteins. APN and 1/18 are established marker proteins for the cLPM and blLPM 
domains of rat liver, respectively. B to E: Rat liver was fixed and processed for 
immunofluorescence using antibodies against caveolin-1, reggie-1 and the established 
canalicular marker Mrp2 (B) as described in Materials and Methods. C/D: Caveolin-1 
labeled the cLPM domain (C) and colocalized with Mrp2 (D). Additional caveolin-1 
labeling was also seen along the sinusoidal lining of hepatocytes (C,D) most probably 
reflecting caveolin-1 expression in sinusoidal lining endothelial cells. Nuclei (blue) 
were stained with DAPI. E: Reggie-1 labeling was seen in the blLPM and cLPM of 
hepatocytes.




Figure4: Immunoelectron microscopic localization of Mrp2 and caveolin-1 in the 
canaliculus: Low power micrograph showing a bile canaliculus with immunogold 
labeling for MRP2 and caveolin-1 (A). At higher magnification (B), immunogold 
labeling for MRP2 (small gold particles, arrowheads) and for caveolin-1 (large gold 
particles, arrows) of the microvilli can be seen. Caveolin-1 immunogold labeling is 
also observed beneath the bile capillary plasma membrane. Original magnifications: 
x38’500 (A), x107’000 (B). 
Figure5: Lipid composition of canalicular DRMs: cLPM were treated with 
1%(w/vol) LubrolWX or 1%(w/vol) TritonX-100 and floated on discontinuous 
sucrose gradients as described in Materials and Methods. Lipids from the recovered 
12 fractions, the resuspended pellets (P) and untreated cLPM (C) were extracted and 
analyzed as described in Materials and Methods. Individual lipid species were 
identified by comigration with the purified lipids sphingomyelin (SM),
phosphatidylcholine (PC), phosphatidylserine (PS), phosphatidylinositol (PI), 
phosphatidylethanolamine (PE) and cholesterol (Ch). While "Lubrol-microdomains" 
(fractions 3-5) contained almost quantitatively all canalicular lipid species, "Triton-
domains" (fractions 3-5) were selectively enriched in sphingomyelin, contained a 
minor portion of cholesterol and were completely devoid of phospholipids. A 
representative result of two independent experiments is shown.




Figure6: Distribution of canalicular marker enzymes within and outside 
"Lubrol-microdomains" and "Triton-microdomains". cLPM were extracted with 
1%(w/vol) LubrolWX or 1%(w/vol) TritonX-100 and floated on discontinuous 
sucrose gradients as described in Materials and Methods. The recovered 12 fractions 
and the resuspended pellets (P) were subjected to immunoblot analyses using 
antibodies against APN, ectoATPase and DPPIV as indicated. Untreated cLPMs were 
used as positive control (C). Apparent molecular weights are given on the right. The 
marker enzymes studied were only minimally (APN,DPPIV) or not at all 
(ectoATPase) associated with canalicular DRMs. One representative result out of at 
least two independent experiments is shown.
Figure7: Distribution of canalicular ABC transporters within and outside 
"Lubrol-microdomains" and "Triton-microdomains". cLPMs were extracted with 
1%(w/vol) LubrolWX or 1%(w/vol) TritonX-100 and floated on discontinuous 
sucrose gradients as described in Materials and Methods. The recovered 12 fractions 
and the resuspended pellets (P) were subjected to Western blot analysis using 
antibodies against the ABC transporters indicated on the left side. Untreated cLPMs 
were used as positive control (C). Apparent molecular weights are given on the right. 
Canalicular ABC transporters were found to reside in part in "Lubrol-microdomains" 
and to be virtually absent from "Triton-microdomains". Only Mdr1 and Mrp2 
remained associated to some degree with "Triton-microdomains". One representative 
result out of at least two independent experiments is shown.
Page 28 of 41
Hepatology
Hepatology
275x190mm (300 x 300 DPI)  
Page 29 of 41
Hepatology
Hepatology
286x190mm (300 x 300 DPI)  
Page 30 of 41
Hepatology
Hepatology
255x190mm (300 x 300 DPI)  
Page 31 of 41
Hepatology
Hepatology
275x190mm (300 x 300 DPI)  
Page 32 of 41
Hepatology
Hepatology
275x190mm (300 x 300 DPI)  
Page 33 of 41
Hepatology
Hepatology
120x163mm (466 x 466 DPI)  
Page 34 of 41
Hepatology
Hepatology
281x190mm (300 x 300 DPI)  
Page 35 of 41
Hepatology
Hepatology
275x190mm (300 x 300 DPI)  
Page 36 of 41
Hepatology
Hepatology
275x190mm (300 x 300 DPI)  





Antibodies: A polyclonal antiserum (pABs) was raised in rabbits against an oligopeptide 
corresponding to the N-terminal 15 amino acids of rat Abcg5 coupled at the C-terminus via an 
additional C-terminal cysteine to keyhole limpet hemocyanine (Neosystems, Strasbourg, 
France) as described in (1). The production of pABs against Bsep and Mrp2 has been 
described previously (2, 3). Hybridomas producing monoclonal antibodies (mABs) against 
aminopeptidase N (APN) (BB4/33) and dipeptidylpeptidase IV (DPPIV) (CLB 4/44) were 
provided by Dr. A. Quaroni (Cornell State University, Ithaca, NY) (4). The mABs 
recognizing ectoATPase and the blLPM marker 1/18 have been described previously (4). 
mABs against Mdr1 (C219) and Mdr2 (P3II-26) were from Alexis Biochemicals (Lausen, 
Switzerland). Anti-Caveolin-1 pABs and mABs, anti-reggie1/flotillin-2 mABs and anti-
reggie2/flotillin-1 mABs were purchased from BD Transduction Laboratories (Heidelberg, 
Germany) and anti pan-actin pABs (pan Ab-5) were from Lab Vision (Basel, Switzerland). 
Goat anti mouse-Alexa488 was obtained from Invitrogen Molecular Probes (Carlsbad, CA) 
and donkey anti rabbit-Cy3 was from Jackson ImmunoResearch Laboratories (West Grove, 
PA). 
Extraction and analysis of lipids: Lipids were extracted from cLPM and DRMs according to 
Bligh and Dyer as described (5). Briefly, 205µg cLPM or 200µl DRM-fractions were brought 
to 800µl with water and extracted with 3ml methanol:trichloromethane (2:1(vol/vol)) for 
20min. at room temperature. The extracts were centrifuged for 5min. at 1400gav, the lipid 
containing supernatants collected and the remaining pellets reextracted with 1ml 
trichloromethane. After another centrifugation, the pooled supernatants were mixed with 1ml 
0.1M KCl and centrifuged again to obtain phase separation. The upper phase was completely 
removed and the lipids from the lower phase were dried under a stream of nitrogen, 
redissolved in 500µl trichloromethane, and stored at –20°C until used. 




Lipids were separated by high performance thin layer chromatography using a modified 
method of Schmitz and Assmann as detailed in (5) for phospholipids. For the separation of 
cholesterol, the plates were developed twice in n-hexane:n-heptane:diethyl ether: acetic acid 
(63:18.5:18.5:1(vol/vol)) and subsequently processed as for separation of phospholipids. 
Quantification of individual lipids was performed with a Camag Scanner II (CAMAG, 
Muttenz, Switzerland) 
Protein concentration was measured using the bicinchoninic acid assay (Interchim, 
Montfuçon, France) with bovine serum albumin as a standard. 
SDS-polyacrylamide gel electrophoresis and immunoblotting: For protein analysis, 
aliquots of membrane fractions were processed by electrophoresis and transferred to 
nitrocellulose membranes as described (4). For detection of proteins, nitrocellulose 
membranes were blocked for 1h with 5%(w/vol) non-fat dry milk dissolved in TBS-T (10mM 
Tris-HCl pH7.6, 150mM NaCl, 0.1 %(vol/vol) Tween20), incubated with primary antibodies 
in TBS-T for either 2h at room temperature or over night at 4°C followed by three 10min. 
washes in TBS-T. The blots were then incubated for 1h at RT with the appropriate secondary 
antibodies diluted in TBS-T/5%(w/vol) dry milk, washed three times in TBS-T and developed 
with the UptiLight chemiluminesence reagent (Interchim). 
Immunofluorescence: Rat livers were quickly removed after decapitation, processed into 
small cubic pieces, frozen in dry ice and stored at -80°C until use. 6µM cryosections were 
fixed for 10min. in methanol at 4°C. After 3 rinses for 5min. in PBS, sections were air-dried 
for 20min. at RT and thereafter incubated with the primary antibodies at appropriate dilutions 
in PBS containing 0.2%(vol/vol) TritonX-100 and 2%(vol/vol) donkey serum at 4°C over 
night. Following 3 rinses with PBS for 5min., the sections were incubated for 60min. at RT 
with secondary antibodies in the buffer used for primary antibodies. Finally, the sections were 




rinsed again 3 times for 5min. with PBS and cover-slipped with Shandon immumount 
(Thermo Electron Corp., Pittsburgh, PA). Sections were analyzed with fluorescence 
microscopy using a Zeiss Axiovert (Zeiss, Göttingen, Germany). Alternatively (Fig.3E), 
cryosections were fixed for 5min in methanol at 4°C. After rinsing with PBS, sections were 
transferred to the blocking solution (1%(w/vol) BSA in PBS) for 30min and rinsed again. The 
sections were incubated with the primary antibody overnight at 4°C and after rinsing with 
PBS exposed to the secondary antibody. Analysis of antibody staining was performed with a 
Zeiss LSM510 system. 
Immunoelectron microscopy. Thin slices (about 1 mm) of rat liver were fixed by immersion 
in ice-cold methanol for 30 min. Afterwards, they were placed in 0.6 M sucrose in PBS (10 
mM phosphate buffer - 0.1M NaCl, pH 7.2) at ambient temperature and cut into 1 mm
3
pieces. After 20 min, the tissue pieces were transferred in 1.2 M sucrose in PBS for 40 min 
and finally in 2.3 M sucrose in PBS for 4 hours. Tissue pieces mounted on aluminium pins 
were frozen and stored in liquid nitrogen. Ultrathin frozen sections (about 70 nm thin) were 
prepared with a cryo diamond knife (Diatome, Biel, Switzerland) using a Leica EM UC6 
ultramicrotome equipped with a Leica EM LC6 cryochamber and picked up on nickel grids 
according to Tokuyasu (6, 7) and stored overnight on gelatin at 4
o
C. Prior to immunolabeling, 
gelatin was liquefied at 37
o
C, nickels grids removed and washed by floating them on droplets 
of PBS (pH 7.4). For double immunogold labeling, grids with the attached sections were 
floated on droplets of a mixture of appropriately diluted anti-Mrp2 and anti-caveolin-1 
antibodies for 2 hours at ambient temperature. After rinses with PBS, grids were incubated on 
droplets of a mixture of gold-labeled affinity-purified goat anti-rabbit IgG (6 nm gold 
particles) and gold-labeled affinity purified goat anti-mouse IgG (12 nm gold particles) for 1 
hour at ambient temperature. Finally, grids with the attached thin sections were rinsed in PBS, 
fixed with 2% (w/vol) glutaraldehyde in PBS for 10-20 min, rinsed with PBS and distilled 




water, and embedded and stained with methylcellulose and uranyl acetate according to 
Tokuyasu (6, 7). 
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